Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 1:01 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | CHI Advisors LLC | 6,449,856 5.14% | 6,449,856 (New Position) | View |
| 2022-02-09 10:24 am Sale | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | FMR LLC | 8,611,375 6.961% | -372,100 (-4.14%) | View |
| 2022-02-04 06:10 am Sale | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Artisan Partners Limited Partnership | 9,816,108 7.8% | -4,444,916 (-31.17%) | View |
| 2021-06-09 09:45 am Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Artisan Partners Limited Partnership | 14,261,024 11.5% | 14,261,024 (New Position) | View |
| 2021-03-16 11:38 am Sale | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | FMR LLC | 8,983,475 7.262% | -3,261,115 (-26.63%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | RA CAPITAL MANAGEMENT L.P. | 12,315,213 12.6% | 1,950,555 (+18.82%) | View |
| 2021-02-16 12:24 pm Sale | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | PRICE T ROWE ASSOCIATES INC | 1,350,835 1.3% | -4,118,623 (-75.30%) | View |
| 2021-02-12 12:30 pm Sale | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Flynn James E | 6,949,416 7.11% | -1,912,831 (-21.58%) | View |
| 2021-02-08 10:13 am Sale | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | FMR LLC | 12,244,590 12.686% | -28,474 (-0.23%) | View |
| 2020-04-09 4:56 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | RA CAPITAL MANAGEMENT L.P. | 10,364,658 10.7% | 3,974,757 (+62.20%) | View |
| 2020-02-14 4:34 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | RA CAPITAL MANAGEMENT L.P. | 6,389,901 6.6% | 1,543,968 (+31.86%) | View |
| 2020-02-14 1:30 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | PRICE T ROWE ASSOCIATES INC | 5,469,458 5.7% | 5,469,458 (New Position) | View |
| 2020-02-13 12:47 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Flynn James E | 8,862,247 9.18% | 838,647 (+10.45%) | View |
| 2020-02-07 11:10 am Sale | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | FMR LLC | 12,273,064 12.715% | -8,134,586 (-39.86%) | View |
| 2020-02-07 10:51 am Unchanged | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Temasek Holdings (Private) Ltd | 4,319,049 4.5% | 0 (Unchanged) | View |
| 2019-05-10 2:56 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | GSK plc GSK | 12,455,252 14.5% | 12,455,252 (New Position) | View |